Market Newsdesk

BOSTON, Dec. 08, 2020 (GLOBE NEWSWIRE) — Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, announces that it has filed a class action lawsuit on behalf of shareholders against Minerva Neurosciences, Inc. (NASDAQ: NERV) and certain of its executives for securities fraud. Investors who purchased NERV shares between May 15, 2017 and November 30, 2020 and who lost money are strongly encouraged to contact Block & Leviton attorneys at (617) 398-5600, via email at [email protected], or at https://www.blockleviton.com/cases/nerv. The lead plaintiff deadline is February 8, 2021.

On December 1, 2020, Minerva announced the results of its meeting with the U.S. Food and Drug Administration concerning Minerva’s attempt to submit a New Drug Application for roluperidone, to treat negative symptoms in schizophrenia. The FDA advised that an NDA submission based on Minerva’s current data from two studies “would be highly unlikely to be filed” and that doing so would present “substantial review issues due to the lack of two adequate and well-controlled trials to support efficacy claims.” The market was stunned by this development, and as a result, Minerva shares fell approximately 26% in one day.

This most recent development follows Minerva’s May 29, 2020 announcement of the results of its Phase III clinical trial for the use of roluperidone to treat negative symptoms in schizophrenia. The Phase III study failed to show statistically significant differences from placebo on both the primary and key secondary endpoints. Minerva shares fell approximately 72.5% on that development.

The lawsuit was filed in the U.S. District Court for the District of Massachusetts, located at the John Joseph Moakley U.S. Courthouse, 1 Courthouse Way, Suite 2300, Boston, MA 02210. The case is captioned McCoy v. Minerva Neurosciences, Inc., et al., No. 1:20-cv-12176-GAO (D. Mass.), and has been assigned to the Hon. George A. O’Toole, Jr.

If you purchased or acquired shares of Minerva between May 15, 2017 and November 30, 2020 and have questions about your legal rights or possess information relevant to this matter, please contact Block & Leviton attorneys at (617) 398-5600, via email at [email protected], or at https://www.blockleviton.com/cases/nerv. The deadline to seek appointment as lead plaintiff in the matter is February 8, 2021.

Block & Leviton LLP is a firm dedicated to representing investors and maintaining the integrity of the country’s financial markets. The firm represents many of the nation’s largest institutional investors as well as individual investors in securities litigation throughout the United States. The firm’s lawyers have recovered billions of dollars for its clients.

This notice may constitute attorney advertising.

CONTACT:
BLOCK & LEVITON LLP
260 Franklin St., Suite 1860
Boston, MA 02110
Phone: (617) 398-5600
Email: [email protected]
SOURCE: Block & Leviton LLP
www.blockleviton.com 

NEW YORK, Dec. 08, 2020 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of CounterPath Corporation (NASDAQ: CPAH) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by an affiliate of Alianza, Inc.

Click here to learn more and participate in the action.

On December 7, 2020, CounterPath announced that it had signed an agreement to be acquired by Alianza for approximately $25.7 million. Pursuant to the merger agreement, CounterPath stockholders will receive $3.49 in cash for each share of CounterPath common stock owned.   The deal is scheduled to close in the first quarter of 2021.

Bragar Eagel & Squire is concerned that CounterPath’s board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for CounterPath’s stockholders.

If you own shares of CounterPath and are concerned about the proposed merger, or you are interested in learning more about the investigation or your legal rights and remedies, please contact Melissa Fortunato or Alexandra Raymond by email at [email protected] or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.
Melissa Fortunato, Esq.
Alexandra Raymond, Esq.
[email protected]
www.bespc.com

Syracuse, New York, Dec. 08, 2020 (GLOBE NEWSWIRE) — Inc. Magazine, in partnership with Syracuse University’s Institute for Veterans and Military Families (IVMF), has announced its annual Vet100 list—a compilation of the nation’s fastest-growing veteran-owned and -operated businesses. The ranking was born out of the iconic Inc. 5000 list of the fastest-growing private companies based in the U.S. Both distinctions are considered hallmarks of entrepreneurial success.

Powered by Fiserv and originally established as the Vet50 list, this year’s list is the third iteration expanded to include 100 veteran-owned and -operated businesses in acknowledgment of the growing culture and success of veteran entrepreneurs.  

“Business growth is a real economic driver in this country and the fact is that most of the new jobs in the economy—over 87 percent—are created by private businesses,” says Eric Schurenberg, CEO of Mansueto Ventures, publisher of Inc. Magazine. “Veteran entrepreneurs contribute their share to the job story, employing over 5.5 million. They deserve to be recognized for their continued service to the country.”

This year’s honorees have an average combined revenue of $23.4M and 17 CEOs/companies on this year’s list are alumni of the IVMF’s award-winning entrepreneurship programs. Twelve companies are repeat Vet100 honorees, including seven from the inaugural Vet50 list in 2017.

“Military experience provides veteran entrepreneurs with the skills and knowledge needed to be successful in the business world,” said Mike Haynie, Syracuse University Vice Chancellor and IVMF Founder and Executive Director. “This year’s list showcases explosive growth in the midst of an extraordinarily challenging business environment. These veteran business owners, nearly 20% of whom have benefitted from an IVMF training program, continue to serve by growing their business, hiring employees and giving back to their communities. Our partnership with Inc. magazine is critical to highlighting the success of these veteran-owned businesses.”

Vet100 honorees will be formally recognized during the Vet100 Dinner and Awards Ceremony as part of IVMF’s Veteran EDGE Conference, to be held in Dallas, TX. EDGE is the first-of-its-kind coalition of large companies supporting the success of veteran-owned businesses, connecting them with entrepreneurial education, training, resources, and networking opportunities.

For more information on the Inc. Vet100 list, visit https://ivmf.syracuse.edu/Vet100/. 

About Inc. and the Inc. 5000

About Inc. Media

The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. For more information, visit www.inc.com.

About Syracuse University’s Institute for Veterans and Military Families

Syracuse University’s Institute for Veterans and Military Families (IVMF) delivers no-cost career training and entrepreneurship programs across the US and globally. And we help ease the transition after service back into communities for service members, veterans and their families as well as prepare them for successful careers and business ownership. We’ve supported over 150,000 to date. It’s our mission to support theirs. For more information, visit ivmf.syracuse.edu and follow the IVMF on Facebook, Twitter and Instagram.

Attachment

• Vet100 2021 Image

NEW YORK, Dec. 08, 2020 (GLOBE NEWSWIRE) — Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Celsion Corporation (NASDAQ: CLSN) from November 2, 2015 through July 10, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Celsion Corporation investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email [email protected] for information on the class action.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) defendants had significantly overstated the efficacy of ThermoDox; (2) the foregoing significantly diminished the approval and commercialization prospects for ThermoDox; (3) as a result, the Company’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

If you wish to serve as lead plaintiff, you must move the Court no later than December 29, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

No class has been certified. Until a class is certified, you are not represented by counsel unless you hire one. You may hire counsel of your choice. You may also do nothing at this time and be an absent member of the class. Your ability to share in any future recovery is not dependent upon being a lead plaintiff.

Pawar Law Group represents investors from around the world. Attorney advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
——————————-

Contact:  
Vik Pawar, Esq.  
Pawar Law Group  
20 Vesey Street, Suite 1410  
New York, NY 10007  
Tel: (917) 261-2277  
Fax: (212) 571-0938  
[email protected] 

CHICAGO, Dec. 08, 2020 (GLOBE NEWSWIRE) — Today, HIMSS announces the launch of a new Office of Scientific Research, a learning community for health sector stakeholders around the globe. The Office of Scientific Research (OSR), aims to focus on the creation of robust empirical evidence around digital health, delivering critical – and actionable – insights and best practices that will power the future of healthcare.

Digital health transformation varies widely across the globe with different goals to achieve and populations to serve within every health system. With this variability, it is critical that insights, knowledge and evidence of clinical, financial and operational improvement be accessible and shared to drive improved outcomes as digital health transformation accelerates.

“With the velocity information is shared today, key intelligence and best practices are constantly being defined and redefined,” said Reid Oakes, Executive Vice President of Analytics for HIMSS. “The future of healthcare relies on ensuring the information we have at our fingertips, is evaluated and validated to drive the innovation that will create pathways for broadening health equity and improved clinical, financial, and operational outcomes. The HIMSS Office of Scientific Research was created to convene the best health sector partners, harness intelligence and make it globally accessible to power the future of healthcare.”

Initial areas of focus for OSR include:

• Operational performance of health systems
• Equity in access to health services and equity as it relates to health outcomes
• Health outcomes and the personalization of healthcare delivery
• Impact of digital health ecosystems on health workforce outcomes
• Global impact of digital capacity and health system performance across jurisdictions

To learn more about OSR and how your organization can partner with HIMSS, connect with us.

About HIMSS

Healthcare Information and Management Systems Society, Inc. (HIMSS) is a global advisor and thought leader supporting the transformation of the health ecosystem through information and technology. As a mission-driven non-profit, HIMSS offers a unique depth and breadth of expertise in health innovation, public policy, workforce development, research and analytics to advise global leaders, stakeholders and influencers on best practices in health information and technology. Through our innovation engine, HIMSS delivers key insights, education and engaging events to healthcare providers, governments and market suppliers, ensuring they have the right information at the point of decision.

Headquartered in Chicago, Illinois, HIMSS serves the global health information and technology communities with focused operations across North America, Europe, the United Kingdom, the Middle East and Asia Pacific. Our members include more than 80,000 individuals, 480 provider organizations, 470 non-profit partners and 650 health services organizations.

Karen D. Groppe

Senior Director, Strategic Communications
Mobile 312.965.7898  | Twitter @Karen_D_Groppe